LIBERA BIO
Libera Bio aims at changing cancer therapy by allowing biologics to cross the cell membrane and reach “undruggable” intracellular targets: the “Holy Grail” in oncology
LIBERA BIO
Industry:
Biopharma Life Science Pharmaceutical
Founded:
2020-01-01
Address:
Santiago De Compostela, Galicia, Spain
Country:
Spain
Website Url:
http://www.liberabio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Nginx Sitelinks Search Box
Current Employees Featured
Founder
Investors List
Xesgalicia
Xesgalicia investment in Seed Round - Libera Bio
Inaki Berenguer
Inaki Berenguer investment in Seed Round - Libera Bio
Innova-Tech Consulting
Innova-Tech Consulting investment in Seed Round - Libera Bio
Xesgalicia
Xesgalicia investment in Seed Round - Libera Bio
Newest Events participated
Participated in 25th Healthcare Investment Forum - Barcelona 2019
on 2019-10-23 as exhibitor
Official Site Inspections
http://www.liberabio.com Semrush global rank: 7.34 M Semrush visits lastest month: 515
- Host name: serv2.imasdmarketing.es
- IP address: 37.187.155.94
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Libera Bio"
Libera Bio | Addressing undruggable intracellular targets in oncology
Libera Bio aims at changing cancer therapy by allowing biologics to cross the cell membrane and reach “undruggable” intracellular targets: the “Holy Grail” in oncology.See details»
Libera Bio Company Profile 2024: Valuation, Funding & Investors
Developer of anti-cancer drugs designed to address the medical needs in oncology focused on intracellular targets.See details»
Libera Bio - Crunchbase Company Profile & Funding
Libera Bio aims at changing cancer therapy by allowing biologics to cross the cell membrane and reach “undruggable” intracellular targets: the “Holy Grail” in oncology. A proprietary …See details»
LiberaBio - LinkedIn
LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells …See details»
Libera Bio - Products, Competitors, Financials, Employees, …
Libera Bio is a biopharmaceutical company focused on the development of new therapeutics for cancer, particularly by addressing 'undruggable' intracellular targets.See details»
Libera Bio | AseBio - Asociación Empresas Biotecnología
Libera Bio® is a biopharma preclinical-stage company spun off from the laboratory of Professor María José Alonso, worldwide leader in Nanomedicine, at the University of Santiago de …See details»
Libera Bio, a pioneer in delivering whole antibodies to high-value ...
A preclinical biotech company focused on the delivery of large biologics to intracellular targets. The technology is also able to improve biodistribution of small molecules that may help reduce …See details»
LiberaBio | Socios Bioga
Libera Bio aims to change cancer therapy by enabling biologics to cross the cell membrane and reach “untreatable” intracellular targets – the “Holy Grail” of oncology.See details»
Maria Jose Alonso - Founder and CSO of LiberaBio at LiberaBio
In 2018, Maria Jose Alonso founded LiberaBio and served as its Chief Scientific Officer. Maria Jose also became the President of the Controlled Release Society in the same year. …See details»
María José Alonso and Libera Bio, awarded by the US
May 26, 2021 · The Salisbury Award program was established in 2019 in honor of three family members whose shared vision and legacy have defined NFCR’s mission and continue to guide the organization’s commitment to funding “high …See details»
ImmunoPrecise Antibodies’ Subsidiary Talem ... - Business Wire
Mar 15, 2023 · Libera Bio’s Multifunctional Polymeric Nanocapsules (MPN Technology®) offer an elegant way to deliver antibodies inside tumor cells. The relevant antibodies are encapsulated …See details»
New Multi-Target AI-Driven Antibody Discovery ... - Libera Bio
Mar 15, 2023 · We are excited to announce that Talem Therapeutics, a subsidiary of IPA (ImmunoPrecise Antibodies), and LiberaBio have entered into a collaborative, multi-target AI …See details»
LiberaBio - LinkedIn
LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells …See details»
Founders' story: Libera Bio - MedCity News
May 28, 2020 · In an interview with MedCity News, the founder and CSO of Spanish biotech startup Libera Bio talked about her company's ambitions to apply its precision medicine …See details»
Libera Bio, a pioneer in delivering whole antibodies to high-value ...
Jul 4, 2022 · The company was formed in 2020 as a spin-off from the University of Santiago de Compostela and the laboratory of Prof. María José Alonso, a global expert in nanodelivery. …See details»
Libera Bio S.L - VentureRadar
Website: https://www.liberabio.com/ Develops innovative biopharmaceutical therapies targeting unmet cancer needs by enabling biologics to cross cell membranes and reach intracellular …See details»
EVQLV and Libera Bio collaborate to develop and deliver novel ...
Libera Bio’s Multifunctional Polymeric Nanocapsules (MPN Technology®) offer an elegant way to deliver antibodies inside tumor cells. The relevant antibodies are encapsulated in …See details»
Libera Bio - EU-Startups
Libera Bio leverages its unique proprietary nanotechnology to hold and protect biologicals (e.g., antibodies) in the blood stream following IV administration and to deliver them intracellularly to …See details»
Libera Bio announced today that it has closed its Seed Round to …
Jul 15, 2022 · Libera Bio announced today that it has closed its Seed Round to advance its MPN Technology® into enabling studies and towards the clinic. More information.See details»
Libera Bio Company Information - Funding, Investors, and More
Jan 1, 2022 · Get information on funding, investors, industries, and more for Libera Bio. See Libera Bio company profile and funding data.See details»